RSS
liothyronine tablets
Pharma company has been accused by CMA of overcharging the NHS
The Competition and Markets Authority (CMA) has released a statement alleging that drug company, Concordia, has abused its position with the NHS to overcharge for liothyronine tablets — an essential thyroid drug. Read more
